在状复合癌中新辅助化疗:改善手术安全性和切除结果
Mubashirah Sajid Charolia1, Fatima Suleman2, Muhammad Shahzad Shamim2
1Resident Neurosurgery, Aga Khan University Hospital, Karachi.
JPMA. The Journal of the Pakistan Medical Association
|February 25, 2026
概括
手术前的化疗,使用和埃托化物,可以缩小罕见的儿科脑瘤,称为胆脉癌 (CPC). 这减少了手术期间的出血,改善了患有这种罕见癌症的儿童的治疗结果.
科学领域:
- 儿科神经瘤学 儿童神经瘤学
- 神经外科 神经外科
- 医学瘤学 医学瘤学
背景情况:
- 状复合癌 (CPC) 是一种罕见的,高度血管性儿科脑瘤.
- 完整的手术切除对于生存至关重要,但往往会因严重的手术内出血而复杂化.
- 新辅助化疗正在研究,以减少瘤大小和手术前的血管性.
研究的目的:
- 审查现有的关于手术前化疗治疗胆脉癌的文献.
- 评估新辅助化疗对CPC患者手术结果的影响.
主要方法:
- 报道的病例和小系列的文献综述,涉及CPC的手术前化疗.
- 对化疗方案,瘤反应和手术结果的分析,包括血液损失和切除完整性.
主要成果:
- 基于和埃托波的化疗方案在减少瘤大小方面表现出有效性.
- 手术前的化疗与手术内流血的减少有关.
- 通过新辅助治疗,更安全,更完整的外科切除得到了促进.
结论:
- 手术前的化疗显示出改善手术切除能力和胆脉癌的结果的前景.
- 进一步进行大规模的多中心研究是必要的,以验证这些发现,并为这种罕见的儿科脑瘤建立标准化的治疗方案.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

